Nuvalent Inc (NUVL)
86.88
-3.30
(-3.66%)
USD |
NASDAQ |
Nov 15, 16:00
86.84
-0.04
(-0.05%)
After-Hours: 20:00
Nuvalent Total Assets (Quarterly): 1.189B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.189B |
| June 30, 2024 | 675.23M |
| March 31, 2024 | 708.47M |
| December 31, 2023 | 732.38M |
| September 30, 2023 | 425.08M |
| June 30, 2023 | 441.95M |
| March 31, 2023 | 460.99M |
| December 31, 2022 | 482.46M |
| Date | Value |
|---|---|
| September 30, 2022 | 249.56M |
| June 30, 2022 | 263.02M |
| March 31, 2022 | 277.04M |
| December 31, 2021 | 293.82M |
| September 30, 2021 | 307.97M |
| June 30, 2021 | 143.50M |
| March 31, 2021 | 15.25M |
| December 31, 2020 | 10.65M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
10.65M
Minimum
Dec 2020
1.189B
Maximum
Sep 2024
417.26M
Average
366.53M
Median
Total Assets (Quarterly) Benchmarks
| Viking Therapeutics Inc | 937.89M |
| Bristol-Myers Squibb Co | 93.67B |
| Replimune Group Inc | 498.20M |
| Moderna Inc | 15.80B |
| NovaBay Pharmaceuticals Inc | 3.877M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 67.73M |
| Shareholders Equity (Quarterly) | 1.121B |